JP2023507387A5 - - Google Patents
Info
- Publication number
- JP2023507387A5 JP2023507387A5 JP2022537270A JP2022537270A JP2023507387A5 JP 2023507387 A5 JP2023507387 A5 JP 2023507387A5 JP 2022537270 A JP2022537270 A JP 2022537270A JP 2022537270 A JP2022537270 A JP 2022537270A JP 2023507387 A5 JP2023507387 A5 JP 2023507387A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- liver disease
- pharmaceuticals
- disorder
- pharmaceuticals according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962951615P | 2019-12-20 | 2019-12-20 | |
| US62/951,615 | 2019-12-20 | ||
| PCT/US2020/066079 WO2021127483A1 (en) | 2019-12-20 | 2020-12-18 | Combination treatment of liver diseases using integrin inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023507387A JP2023507387A (ja) | 2023-02-22 |
| JP2023507387A5 true JP2023507387A5 (enExample) | 2023-10-26 |
Family
ID=74186956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022537270A Pending JP2023507387A (ja) | 2019-12-20 | 2020-12-18 | インテグリン阻害剤を使用する肝疾患の治療の組み合わせ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230055657A1 (enExample) |
| EP (1) | EP4076455A1 (enExample) |
| JP (1) | JP2023507387A (enExample) |
| KR (1) | KR20220121838A (enExample) |
| CN (1) | CN114929219A (enExample) |
| AR (1) | AR120859A1 (enExample) |
| AU (1) | AU2020405182B2 (enExample) |
| CA (1) | CA3165000A1 (enExample) |
| IL (1) | IL293895A (enExample) |
| TW (1) | TW202135812A (enExample) |
| WO (1) | WO2021127483A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220220206A1 (en) * | 2019-05-20 | 2022-07-14 | Mayo Foundation For Medical Education And Research | Treating chronic liver disease |
| US20230060422A1 (en) * | 2019-12-20 | 2023-03-02 | Novartis Ag | Combination treatment of liver diseases using integrin inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU24152B1 (es) | 2010-12-20 | 2016-02-29 | Irm Llc | 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr |
| EP3509590A4 (en) * | 2016-09-07 | 2020-12-02 | Pliant Therapeutics, Inc. | N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE |
| RU2019110780A (ru) * | 2016-09-14 | 2020-10-15 | Новартис Аг | Комбинация агонистов fxr |
| TWI841573B (zh) * | 2018-06-27 | 2024-05-11 | 美商普萊恩醫療公司 | 具有未分支連接子之胺基酸化合物及使用方法 |
| CN118852054A (zh) * | 2019-02-06 | 2024-10-29 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途 |
-
2020
- 2020-12-18 TW TW109145129A patent/TW202135812A/zh unknown
- 2020-12-18 EP EP20842496.0A patent/EP4076455A1/en not_active Withdrawn
- 2020-12-18 AU AU2020405182A patent/AU2020405182B2/en not_active Ceased
- 2020-12-18 KR KR1020227024756A patent/KR20220121838A/ko active Pending
- 2020-12-18 CA CA3165000A patent/CA3165000A1/en active Pending
- 2020-12-18 WO PCT/US2020/066079 patent/WO2021127483A1/en not_active Ceased
- 2020-12-18 IL IL293895A patent/IL293895A/en unknown
- 2020-12-18 CN CN202080088263.6A patent/CN114929219A/zh active Pending
- 2020-12-18 JP JP2022537270A patent/JP2023507387A/ja active Pending
- 2020-12-18 US US17/786,499 patent/US20230055657A1/en not_active Abandoned
- 2020-12-21 AR ARP200103597A patent/AR120859A1/es unknown